| 1 | Abruptio Placentae | 32.1% |
| 2 | Placenta Accreta | 32.1% |
| 3 | Polyhydramnios | 30% |
| 4 | Obstetric Labor Complications | 30% |
| 5 | Ectopic Pregnancy | 30% |
| 6 | Pregnancy, Prolonged | 30% |
| 7 | Puerperal Disorders | 30% |
| 8 | Oligohydramnios | 30% |
| 9 | Prenatal Injuries | 30% |
| 10 | Chorioamnionitis | 29.8% |
| 11 | Puerperal Infection | 25.4% |
| 12 | Postpartum Hemorrhage | 25.2% |
| 13 | Fetal Diseases | 23.1% |
| 14 | Pregnancy Complications, Cardiovascular | 23.1% |
| 15 | Pregnancy Complications, Hematologic | 22.2% |
| 16 | Pregnancy Complications, Infectious | 22.2% |
| 17 | Abortion, Habitual | 22% |
| 18 | Dystocia | 22% |
| 19 | Eclampsia | 22% |
| 20 | Fetal Membranes, Premature Rupture | 22% |
| 21 | Placental Insufficiency | 22% |
| 22 | Pre-Eclampsia | 22% |
| 23 | Prenatal Exposure Delayed Effects | 22% |
| 24 | HELLP Syndrome | 22% |
| 25 | Placenta, Retained | 22% |
| 26 | Fetal Death | 21.8% |
| 27 | Perinatal death | 21.8% |
| 28 | Morning Sickness | 21.6% |
| 29 | Hamartoma | 21.1% |
| 30 | Neoplasms, Hormone-Dependent | 21.1% |
| 31 | Neoplasms, Multiple Primary | 21.1% |
| 32 | Paraneoplastic Syndromes | 21.1% |
| 33 | Precancerous Conditions | 21.1% |
| 34 | Neoplasms, Second Primary | 21.1% |
| 35 | Carcinoma 256, Walker | 20.7% |
| 36 | Medulloblastoma | 20.7% |
| 37 | Uterine Inversion | 20.4% |
| 38 | Neoplasms, Neuroepithelial | 19.4% |
| 39 | Gliomatosis cerebri | 19.4% |
| 40 | Carcinoma, Ehrlich Tumor | 18.9% |
| 41 | Dermoid Cyst | 18.9% |
| 42 | Carcinoma, Lewis Lung | 18.9% |
| 43 | melanoma | 18.6% |
| 44 | Melanoma, Experimental | 18.2% |
| 45 | Premature Birth | 18.1% |
| 46 | Neuroectodermal Tumors | 17.9% |
| 47 | Adenoma, Acidophil | 17.8% |
| 48 | Ganglioneuroma | 17.8% |
| 49 | Glioma | 17.8% |
| 50 | Malignant Glioma | 17.8% |
| 51 | Carcinoid Tumor | 17.4% |
| 52 | Neurilemmoma | 17.4% |
| 53 | Hutchinson's Melanotic Freckle | 17.4% |
| 54 | Melanoma, Amelanotic | 17.4% |
| 55 | Multiple Endocrine Neoplasia | 17.3% |
| 56 | Gestational Diabetes | 17.3% |
| 57 | Uterine Cervical Incompetence | 17% |
| 58 | Astrocytoma | 17% |
| 59 | Ependymoma | 17% |
| 60 | oligodendroglioma | 17% |
| 61 | Ganglioglioma | 17% |
| 62 | gliosarcoma | 17% |
| 63 | Anaplastic astrocytoma | 17% |
| 64 | Anaplastic Oligodendroglioma | 17% |
| 65 | Abortion, Veterinary | 17% |
| 66 | Pregnancy Complications, Parasitic | 17% |
| 67 | Carcinosarcoma | 16.8% |
| 68 | Hemangiosarcoma | 16.8% |
| 69 | Leukemia L1210 | 16.8% |
| 70 | Leukemia P388 | 16.8% |
| 71 | lymphangiosarcoma | 16.8% |
| 72 | Acanthoma | 16.8% |
| 73 | Malignant Carcinoid Syndrome | 16.8% |
| 74 | Glioblastoma | 16.6% |
| 75 | Neuroblastoma | 16.6% |
| 76 | Glioblastoma Multiforme | 16.6% |
| 77 | Ganglioneuroblastoma | 16.4% |
| 78 | Meningioma | 16.3% |
| 79 | Uterine Rupture | 16.3% |
| 80 | Sarcoma 180 | 16.3% |
| 81 | Lactation Disorder | 16.1% |
| 82 | Mastitis | 16.1% |
| 83 | Depression, Postpartum | 16.1% |
| 84 | Embryo Loss | 16.1% |
| 85 | Paraneoplastic Encephalomyelitis | 15.9% |
| 86 | Fetal Resorption | 15.9% |
| 87 | Hyperemesis Gravidarum | 15.9% |
| 88 | Basal cell carcinoma | 15.8% |
| 89 | Carcinoma, Papillary | 15.8% |
| 90 | Squamous cell carcinoma | 15.8% |
| 91 | Chondrosarcoma | 15.8% |
| 92 | Craniopharyngioma | 15.8% |
| 93 | Cystadenoma | 15.8% |
| 94 | leiomyosarcoma | 15.8% |
| 95 | liposarcoma | 15.8% |
| 96 | Mesothelioma | 15.8% |
| 97 | synovial sarcoma | 15.8% |
| 98 | Neuroectodermal Tumor, Melanotic | 15.8% |
| 99 | Angiomyolipoma | 15.8% |
| 100 | Clear Cell Sarcoma of Soft Tissue | 15.8% |
| 101 | Alveolar Soft Part Sarcoma | 15.8% |
| 102 | Neuroendocrine Tumors | 15.8% |
| 103 | Female Urogenital Diseases | 15.8% |
| 104 | Sarcoma, Myeloid | 15.8% |
| 105 | Carcinoma, Basal Cell | 15.8% |
| 106 | Carcinoma, Lobular | 15.7% |
| 107 | Leukemia, Experimental | 15.6% |
| 108 | Mammary Neoplasms, Experimental | 15.6% |
| 109 | Cyst | 15.4% |
| 110 | Neoplastic Processes | 15.4% |
| 111 | Neoplastic Syndromes, Hereditary | 15.4% |
| 112 | Cystadenocarcinoma | 15.3% |
| 113 | Fibrosarcoma | 15.3% |
| 114 | Osteosarcoma | 15.3% |
| 115 | Mucoepidermoid Carcinoma | 15.3% |
| 116 | Neoplasms, Experimental | 15.1% |
| 117 | Endometrial Stromal Sarcoma | 15.1% |
| 118 | Adenofibroma | 15% |
| 119 | Fibroadenoma | 15% |
| 120 | Malignant Fibrous Histiocytoma | 15% |
| 121 | Abdominal Neoplasms | 15% |
| 122 | Erythroplasia | 15% |
| 123 | Follicular cyst | 15% |
| 124 | Head and Neck Neoplasms | 15% |
| 125 | leukemia | 15% |
| 126 | Mucocele | 15% |
| 127 | Neoplasms, Germ Cell and Embryonal | 15% |
| 128 | Neoplasms, Glandular and Epithelial | 15% |
| 129 | Pilonidal Cyst | 15% |
| 130 | Soft Tissue Neoplasms | 15% |
| 131 | Thoracic Neoplasms | 15% |
| 132 | Thyroglossal Cyst | 15% |
| 133 | Synovial Cyst | 15% |
| 134 | Germ Cell Cancer | 15% |
| 135 | Aberrant Crypt Foci | 15% |
| 136 | Sarcoma, Experimental | 14.8% |
| 137 | Bowen's Disease | 14.8% |
| 138 | Paraganglioma | 14.8% |
| 139 | Rhabdomyosarcoma | 14.8% |
| 140 | Giant Cell Tumor of Bone | 14.8% |
| 141 | Dermatofibrosarcoma | 14.5% |
| 142 | Dermatofibrosarcoma Protuberans | 14.5% |
| 143 | Genital Neoplasms, Female | 14.3% |
| 144 | Pheochromocytoma | 14.3% |
| 145 | Alveolar rhabdomyosarcoma | 14.3% |
| 146 | Multiple Endocrine Neoplasia Type 1 | 14.2% |
| 147 | Carcinoid Heart Disease | 13.9% |
| 148 | Nephroblastoma | 13.3% |
| 149 | Thymoma | 13.3% |
| 150 | Retinoblastoma | 13.2% |
| 151 | Leukemia, Plasma Cell | 13.2% |
| 152 | Galactorrhea | 13.2% |
| 153 | Uterine Neoplasms | 13.1% |
| 154 | Vaginal Neoplasms | 13.1% |
| 155 | Vulvar Neoplasms | 13.1% |
| 156 | Uterine Cancer | 13.1% |
| 157 | Leukemia, Radiation-Induced | 13% |
| 158 | Carcinoma, Pancreatic Ductal | 13% |
| 159 | Fetal Growth Retardation | 12.9% |
| 160 | Acoustic Neuroma | 12.9% |
| 161 | Embolism, Amniotic Fluid | 12.8% |
| 162 | Fetal Hypoxia | 12.8% |
| 163 | Fetal Alcohol Spectrum Disorders | 12.8% |
| 164 | Fallopian Tube Neoplasms | 12.7% |
| 165 | Breech Presentation | 12.5% |
| 166 | Stillbirth | 12.5% |
| 167 | Vipoma | 12.3% |
| 168 | Carcinoma, Endometrioid | 12.3% |
| 169 | Adenoma | 12.2% |
| 170 | Ameloblastoma | 12.2% |
| 171 | Angiokeratoma | 12.2% |
| 172 | Carcinoma | 12.2% |
| 173 | Chordoma | 12.2% |
| 174 | Hemangioma | 12.2% |
| 175 | hemangiopericytoma | 12.2% |
| 176 | Lymphangioma | 12.2% |
| 177 | Mesenchymoma | 12.2% |
| 178 | Nevus | 12.2% |
| 179 | Retroperitoneal Neoplasms | 12.2% |
| 180 | Teratoma | 12.2% |
| 181 | Hepatoblastoma | 12.2% |
| 182 | Mixed Tumor, Mullerian | 12.2% |
| 183 | Germinoma | 12.2% |
| 184 | Teratocarcinoma | 12.2% |
| 185 | Angiofibroma | 12.2% |
| 186 | Sarcoma | 12.2% |
| 187 | Epithelioma | 12.2% |
| 188 | Neurofibrosarcoma | 12% |
| 189 | Endometrial Neoplasms | 11.9% |
| 190 | Parathyroid Neoplasms | 11.9% |
| 191 | Peritoneal Neoplasms | 11.9% |
| 192 | Thyroid Neoplasm | 11.9% |
| 193 | Thyroid carcinoma | 11.9% |
| 194 | Neoplasms, Radiation-Induced | 11.9% |
| 195 | Lymphomatoid Granulomatosis | 11.7% |
| 196 | Corpus Luteum Cyst | 11.7% |
| 197 | Ovarian Cysts | 11.7% |
| 198 | Digestive System Neoplasms | 11.5% |
| 199 | Endocrine Gland Neoplasms | 11.5% |
| 200 | Eye Neoplasms | 11.5% |
| 201 | Nervous System Neoplasms | 11.5% |
| 202 | Mesoblastic Nephroma | 11.5% |
| 203 | Composite Lymphoma | 11.5% |
| 204 | Basal Cell Nevus Syndrome | 11.5% |
| 205 | Optic Nerve Glioma | 11.4% |
| 206 | Urologic Neoplasms | 11.4% |
| 207 | Tuberous Sclerosis | 11.4% |
| 208 | Tracheal Neoplasms | 11.2% |
| 209 | granulosa cell tumor | 11.2% |
| 210 | Carcinoma, Ovarian Epithelial | 11.2% |
| 211 | Bone neoplasms | 11.1% |
| 212 | Leukoplakia | 11.1% |
| 213 | Lymphocele | 11.1% |
| 214 | Pancreatic Cyst | 11.1% |
| 215 | Skin Neoplasms | 11.1% |
| 216 | Hematologic Neoplasms | 11.1% |
| 217 | Leukoplakia, Oral | 11% |
| 218 | Paraneoplastic Cerebellar Degeneration | 10.9% |
| 219 | Barrett Esophagus | 10.9% |
| 220 | Breast Cyst | 10.9% |
| 221 | Histiocytic Disorders, Malignant | 10.9% |
| 222 | Actinic keratosis | 10.9% |
| 223 | Mediastinal Cyst | 10.9% |
| 224 | Neoplasm Invasiveness | 10.9% |
| 225 | Neoplasm Metastasis | 10.9% |
| 226 | Neoplasm Recurrence, Local | 10.9% |
| 227 | Parovarian Cyst | 10.9% |
| 228 | Pericardial Cyst | 10.9% |
| 229 | Splenic Neoplasms | 10.9% |
| 230 | Thymic Cyst | 10.9% |
| 231 | Carcinogenesis | 10.9% |
| 232 | Myxoid cyst | 10.9% |
| 233 | Metastasis | 10.9% |
| 234 | Adenocarcinoma | 10.8% |
| 235 | Carcinoma in Situ | 10.8% |
| 236 | Carcinoma, Transitional Cell | 10.8% |
| 237 | Phyllodes Tumor | 10.8% |
| 238 | Dysgerminoma | 10.8% |
| 239 | Hemangioendothelioma | 10.8% |
| 240 | Lipoma | 10.8% |
| 241 | Myoma | 10.8% |
| 242 | Myxoma | 10.8% |
| 243 | Neuroma | 10.8% |
| 244 | Papilloma | 10.8% |
| 245 | Pseudomyxoma Peritonei | 10.8% |
| 246 | Seminoma | 10.8% |
| 247 | Papillomatosis | 10.8% |
| 248 | Angiolipoma | 10.8% |
| 249 | Myelolipoma | 10.8% |
| 250 | Neoplasms, Bone Tissue | 10.8% |
| 251 | Neoplasms, Fibrous Tissue | 10.8% |
| 252 | Smooth Muscle Tumor | 10.8% |
| 253 | Adenomatosis, Pulmonary | 10.8% |
| 254 | Adenomatous Polyps | 10.8% |
| 255 | Carcinoma, Large Cell | 10.8% |
| 256 | Carcinoma, Small Cell | 10.8% |
| 257 | Desmoplastic Small Round Cell Tumor | 10.8% |
| 258 | Chondroma | 10.8% |
| 259 | Enchondroma | 10.8% |
| 260 | Renal Cell Carcinoma | 10.8% |
| 261 | Papillary Renal Cell Carcinoma | 10.8% |
| 262 | insulinoma | 10.6% |
| 263 | Gastrinoma | 10.5% |
| 264 | Glucagonoma | 10.5% |
| 265 | Liver Neoplasms, Experimental | 10.4% |
| 266 | Thyroid Nodule | 10.3% |
| 267 | Hepatocellular Adenoma | 10.3% |
| 268 | Lymphangioleiomyomatosis | 10.2% |
| 269 | Pancreatic Neoplasm | 10.2% |
| 270 | Adenoid Cystic Carcinoma | 10.2% |
| 271 | fibroma | 10.2% |
| 272 | Fibromatosis | 10.2% |
| 273 | Osteoblastoma | 10.2% |
| 274 | Osteoma | 10.2% |
| 275 | Rhabdomyoma | 10.2% |
| 276 | Chondromatosis | 10.2% |
| 277 | Adenocarcinoma, Clear Cell | 10.2% |
| 278 | Cholangiocarcinoma | 10.2% |
| 279 | Cervical Intraepithelial Neoplasia | 10.2% |
| 280 | Hemangioblastoma | 10.2% |
| 281 | Lymphoma, Extranodal NK-T-Cell | 10.2% |
| 282 | Choriocarcinoma | 10% |
| 283 | Fibromatosis, Aggressive | 9.9% |
| 284 | Fibromatosis, Abdominal | 9.9% |
| 285 | Klatskin Tumor | 9.9% |
| 286 | Polycystic Ovary Syndrome | 9.8% |
| 287 | ovarian neoplasm | 9.6% |
| 288 | Denys-Drash Syndrome | 9.4% |
| 289 | Esophageal Neoplasms | 9.4% |
| 290 | Leydig Cell Tumor | 9.3% |
| 291 | Bladder Neoplasm | 9.3% |
| 292 | Kidney Neoplasm | 9.3% |
| 293 | Ureteral Neoplasms | 9.3% |
| 294 | Urethral Neoplasms | 9.3% |
| 295 | Limbic Encephalitis | 9.3% |
| 296 | Meconium Aspiration Syndrome | 9.2% |
| 297 | Mouth Neoplasms | 9.1% |
| 298 | Central Nervous System Neoplasms | 9.1% |
| 299 | Vascular Neoplasms | 9.1% |
| 300 | Thymus Neoplasms | 9.1% |
| 301 | Pancreatic Pseudocyst | 8.9% |
| 302 | Plasmacytoma | 8.9% |
| 303 | Malignant histiocytosis | 8.8% |
| 304 | Lymphatic Metastasis | 8.8% |
| 305 | Neoplasms, Unknown Primary | 8.8% |
| 306 | Leukemic Infiltration | 8.8% |
| 307 | Breast Neoplasms, Male | 8.8% |
| 308 | Histiocytic sarcoma | 8.8% |
| 309 | Neoplasm Micrometastasis | 8.8% |
| 310 | Triple Negative Breast Neoplasms | 8.8% |
| 311 | Prolactinoma | 8.7% |
| 312 | Growth Hormone-Secreting Pituitary Adenoma | 8.7% |
| 313 | Adenomatous Polyposis Coli | 8.7% |
| 314 | Lymphoma | 8.6% |
| 315 | Endometritis | 8.3% |
| 316 | Lambert-Eaton Myasthenic Syndrome | 8.2% |
| 317 | Testicular Neoplasms | 8.2% |
| 318 | Adrenocortical carcinoma | 8.2% |
| 319 | Meningeal Neoplasms | 8% |
| 320 | Leukemia, Myelomonocytic, Chronic | 7.9% |
| 321 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 7.9% |
| 322 | Salpingitis | 7.8% |
| 323 | Vulvovaginitis | 7.8% |
| 324 | Urologic Diseases | 7.7% |
| 325 | Mastocytoma | 7.5% |
| 326 | Meningeal Carcinomatosis | 7.4% |
| 327 | Mastocytosis, Systemic | 7.4% |
| 328 | Palatal Neoplasms | 7.4% |
| 329 | Leukemia, Myeloid, Chronic-Phase | 7.4% |
| 330 | Endometriosis | 7.3% |
| 331 | Uterine Diseases | 7.3% |
| 332 | Vaginal Diseases | 7.3% |
| 333 | Vulvar Diseases | 7.3% |
| 334 | Endometrioma | 7.3% |
| 335 | Opsoclonus-Myoclonus Syndrome | 7.3% |
| 336 | Adrenal Gland Neoplasms | 7.2% |
| 337 | Gastrointestinal Neoplasms | 7.2% |
| 338 | Genital Neoplasms, Male | 7.2% |
| 339 | Liver neoplasms | 7.2% |
| 340 | Uveal Neoplasms | 7.2% |
| 341 | Choledochal Cyst | 7.1% |
| 342 | Trophoblastic Neoplasms | 7.1% |
| 343 | Sebaceous Gland Neoplasms | 7% |
| 344 | Spinal Neoplasms | 7% |
| 345 | Bone Marrow Neoplasms | 7% |
| 346 | Nose Neoplasms | 7% |
| 347 | Peutz-Jeghers Syndrome | 6.9% |
| 348 | Hodgkin Disease | 6.9% |
| 349 | Lymphoma, Non-Hodgkin | 6.9% |
| 350 | Ear Neoplasms | 6.5% |
| 351 | Eyelid Neoplasms | 6.5% |
| 352 | Lung Neoplasms | 6.5% |
| 353 | Pleural Neoplasms | 6.5% |
| 354 | Vesicovaginal Fistula | 6.5% |
| 355 | Myelitis, Transverse | 6.4% |
| 356 | Nasopharyngeal carcinoma | 6.4% |
| 357 | Mastocytosis | 6.4% |
| 358 | Sturge-Weber Syndrome | 6.4% |
| 359 | Cell Transformation, Viral | 6.3% |
| 360 | Brain Neoplasms | 6.3% |
| 361 | Salivary Gland Neoplasms | 6.3% |
| 362 | Spinal Cord Neoplasms | 6.3% |
| 363 | Tongue Neoplasms | 6.3% |
| 364 | Gastrointestinal Stromal Tumors | 6.3% |
| 365 | Hemangioma, Cavernous | 6.2% |
| 366 | Leukemia, T-Cell | 6.2% |
| 367 | Oophoritis | 6.2% |
| 368 | Leukemia, B-Cell | 6.2% |
| 369 | neurofibroma | 6.2% |
| 370 | Lymphoma, Follicular | 6.2% |
| 371 | T-Cell Lymphoma | 6.2% |
| 372 | Mantle cell lymphoma | 6.2% |
| 373 | Pituitary Adenoma | 6.1% |
| 374 | Pituitary Neoplasms | 6.1% |
| 375 | Urogenital Abnormalities | 6.1% |
| 376 | Endometrial Hyperplasia | 6% |
| 377 | Pyometra | 6% |
| 378 | Vaginitis | 6% |
| 379 | Vulvitis | 6% |
| 380 | Vaginal Discharge | 6% |
| 381 | Vulvodynia | 6% |
| 382 | Bronchial Neoplasms | 6% |
| 383 | Multiple Pulmonary Nodules | 5.9% |
| 384 | Supratentorial Neoplasms | 5.8% |
| 385 | Candidiasis, Vulvovaginal | 5.8% |
| 386 | Hydatidiform Mole | 5.8% |
| 387 | Dupuytren Contracture | 5.8% |
| 388 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 389 | Leukemia, Large Granular Lymphocytic | 5.8% |
| 390 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 5.8% |
| 391 | Lymphoma, T-Cell, Cutaneous | 5.8% |
| 392 | Lymphoma, AIDS-Related | 5.8% |
| 393 | Enteropathy-Associated T-Cell Lymphoma | 5.8% |
| 394 | Primary Effusion Lymphoma | 5.8% |
| 395 | Primary amyloidosis | 5.8% |
| 396 | Anuria | 5.7% |
| 397 | Ureterolithiasis | 5.7% |
| 398 | Nephrolithiasis | 5.7% |
| 399 | Urticaria Pigmentosa | 5.7% |
| 400 | Hydrops Fetalis | 5.7% |
| 401 | Brain Stem Neoplasms | 5.6% |
| 402 | Mycosis Fungoides | 5.6% |
| 403 | Lymphomatoid Papulosis | 5.6% |
| 404 | Plasmablastic lymphoma | 5.6% |
| 405 | Choroid Plexus Papilloma | 5.5% |
| 406 | Bladder Exstrophy | 5.5% |
| 407 | Epispadias | 5.5% |
| 408 | Urinary Bladder Diseases | 5.5% |
| 409 | Infertility | 5.5% |
| 410 | Kidney Diseases | 5.5% |
| 411 | Ureteral Diseases | 5.5% |
| 412 | Urethral Diseases | 5.5% |
| 413 | Urination Disorders | 5.5% |
| 414 | Urolithiasis | 5.5% |
| 415 | Tuberculosis, Renal | 5.4% |
| 416 | Bladder neck obstruction | 5.4% |
| 417 | Uterine Cervicitis | 5.4% |
| 418 | Leukorrhea | 5.4% |
| 419 | Parametritis | 5.4% |
| 420 | Pharyngeal Neoplasms | 5.4% |
| 421 | Central Nervous System Cysts | 5.3% |
| 422 | Bile Duct Neoplasms | 5.2% |
| 423 | gallbladder neoplasm | 5.2% |
| 424 | Intestinal Neoplasms | 5.2% |
| 425 | Penile Neoplasms | 5.2% |
| 426 | Prostatic Neoplasms | 5.2% |
| 427 | Stomach Neoplasms | 5.2% |
| 428 | Multicystic Dysplastic Kidney | 5.2% |
| 429 | Polycythemia Vera | 5.1% |
| 430 | Kidney Calculi | 5% |
| 431 | Ureteral Calculi | 5% |
| 432 | Pyelocystitis | 4.9% |
| 433 | Hypopharyngeal Neoplasms | 4.9% |
| 434 | Pleural Effusion, Malignant | 4.9% |
| 435 | Hypopharyngeal Cancer | 4.9% |
| 436 | Urinary Bladder Fistula | 4.9% |
| 437 | Parotid Neoplasms | 4.8% |
| 438 | Prostatic Neoplasms, Castration-Resistant | 4.8% |
| 439 | Nelson Syndrome | 4.8% |
| 440 | Pyelonephritis | 4.8% |
| 441 | Tonsillar Neoplasms | 4.7% |
| 442 | Cerebellar Neoplasms | 4.6% |
| 443 | Laryngeal neoplasm | 4.6% |
| 444 | Ovarian Diseases | 4.5% |
| 445 | Adnexitis | 4.4% |
| 446 | Cystitis | 4.4% |
| 447 | Hydronephrosis | 4.4% |
| 448 | Hyperoxaluria | 4.4% |
| 449 | Kidney Cortex Necrosis | 4.4% |
| 450 | Kidney Papillary Necrosis | 4.4% |
| 451 | Nephritis | 4.4% |
| 452 | Nephrosclerosis | 4.4% |
| 453 | Nephrosis | 4.4% |
| 454 | Perinephritis | 4.4% |
| 455 | Pruritus Vulvae | 4.4% |
| 456 | Kidney Failure | 4.4% |
| 457 | Uremia | 4.4% |
| 458 | Ureteral obstruction | 4.4% |
| 459 | Ureterocele | 4.4% |
| 460 | Urethral Obstruction | 4.4% |
| 461 | Urethritis | 4.4% |
| 462 | Uterine hemorrhage | 4.4% |
| 463 | Vaginal Fistula | 4.4% |
| 464 | Vesico-Ureteral Reflux | 4.4% |
| 465 | Urinary Retention | 4.4% |
| 466 | Pelvic Inflammatory Disease | 4.4% |
| 467 | Oxalosis | 4.4% |
| 468 | Renal Insufficiency | 4.4% |
| 469 | Uterine Prolapse | 4.4% |
| 470 | Vaginal Prolapse | 4.4% |
| 471 | Urinary tract infection | 4.3% |
| 472 | Horseshoe Kidney | 4.3% |
| 473 | Waldenstrom Macroglobulinemia | 4.3% |
| 474 | Multiple Myeloma | 4.3% |
| 475 | Xeroderma Pigmentosum | 4.1% |
| 476 | Cecal Neoplasms | 4.1% |
| 477 | Duodenal Neoplasms | 4.1% |
| 478 | Burkitt Lymphoma | 4.1% |
| 479 | Bacterial Vaginosis | 4% |
| 480 | Sezary Syndrome | 4% |
| 481 | Radicular Cyst | 4% |
| 482 | Trichomonas Vaginitis | 4% |
| 483 | Uterine Perforation | 4% |
| 484 | Ovarian Hyperstimulation Syndrome | 4% |
| 485 | Appendiceal Neoplasms | 3.9% |
| 486 | Colonic Neoplasms | 3.9% |
| 487 | Rectal Neoplasms | 3.9% |
| 488 | Glomerulonephritis | 3.9% |
| 489 | Metrorrhagia | 3.9% |
| 490 | Nephritis, Interstitial | 3.9% |
| 491 | Lipoid nephrosis | 3.9% |
| 492 | Nephrotic Syndrome | 3.9% |
| 493 | Pyelitis | 3.9% |
| 494 | Pyonephrosis | 3.9% |
| 495 | Urethral Stenosis | 3.9% |
| 496 | Nephrogenic Diabetes Insipidus | 3.9% |
| 497 | Congenital Nephrogenic Diabetes Insipidus | 3.9% |
| 498 | Acute kidney injury | 3.9% |
| 499 | Urethral stricture | 3.9% |
| 500 | Zollinger-Ellison syndrome | 3.8% |
| 501 | Sexually Transmitted Diseases | 3.7% |
| 502 | Balkan Nephropathy | 3.7% |
| 503 | Focal glomerulosclerosis | 3.7% |
| 504 | Kidney Failure, Chronic | 3.7% |
| 505 | Nasopharyngeal Neoplasms | 3.6% |
| 506 | Hermaphroditism | 3.6% |
| 507 | Disorders of Sex Development | 3.6% |
| 508 | Colorectal Neoplasms | 3.6% |
| 509 | Diabetes Insipidus | 3.5% |
| 510 | Hepatorenal Syndrome | 3.5% |
| 511 | Dyspareunia | 3.5% |
| 512 | Hypospadias | 3.5% |
| 513 | Genital Herpes | 3.5% |
| 514 | Bacteriuria | 3.5% |
| 515 | Diabetic Nephropathy | 3.5% |
| 516 | Glycosuria | 3.5% |
| 517 | Hematuria | 3.5% |
| 518 | Renal hypertension | 3.5% |
| 519 | Oliguria | 3.5% |
| 520 | Polyuria | 3.5% |
| 521 | Proteinuria | 3.5% |
| 522 | Pyuria | 3.5% |
| 523 | Renal Artery Obstruction | 3.5% |
| 524 | Renal Artery Stenosis | 3.5% |
| 525 | Urinary Calculi | 3.5% |
| 526 | Cystocele | 3.5% |
| 527 | Nephrocalcinosis | 3.5% |
| 528 | Urinary Incontinence | 3.5% |
| 529 | Anus Neoplasms | 3.4% |
| 530 | Sigmoid Neoplasms | 3.4% |
| 531 | Glycosuria, Renal | 3.3% |
| 532 | Paranasal Sinus Neoplasms | 3.2% |
| 533 | Azotemia | 3.2% |
| 534 | Anovulation | 3.1% |
| 535 | Menorrhagia | 3.1% |
| 536 | Albuminuria | 3.1% |
| 537 | Hemoglobinuria | 3.1% |
| 538 | Hypertension, Renovascular | 3.1% |
| 539 | Premature Menopause | 3.1% |
| 540 | Urge Incontinence | 3.1% |
| 541 | Maxillary Sinus Neoplasms | 3.1% |
| 542 | Glomerulonephritis, Membranoproliferative | 3.1% |
| 543 | Hyperandrogenism | 3% |
| 544 | Enuresis | 2.9% |
| 545 | Gonadal Dysgenesis | 2.9% |
| 546 | Adrenogenital Syndrome | 2.9% |
| 547 | Ovotesticular Disorders of Sex Development | 2.9% |
| 548 | Polycystic Kidney Diseases | 2.6% |
| 549 | Diurnal Enuresis | 2.6% |
| 550 | Renal Aminoacidurias | 2.5% |
| 551 | Fanconi Syndrome | 2.5% |
| 552 | Pseudohypoaldosteronism | 2.5% |
| 553 | Liddle Syndrome | 2.5% |
| 554 | Hemolytic-Uremic Syndrome | 2.5% |
| 555 | Anti-Glomerular Basement Membrane Disease | 2.5% |
| 556 | AIDS-Associated Nephropathy | 2.4% |
| 557 | Lupus Nephritis | 2.4% |
| 558 | Polycystic Kidney, Autosomal Dominant | 2.4% |
| 559 | Cystinuria | 2.4% |
| 560 | Atypical Hemolytic Uremic Syndrome | 2.4% |
| 561 | Chlamydia Infections | 2.2% |
| 562 | Gonorrhea | 2.2% |
| 563 | Renal tubular acidosis | 2.2% |
| 564 | Lymphogranuloma Venereum | 2% |
| 565 | Turner Syndrome | 2% |
| 566 | Kallmann Syndrome | 1.9% |
| 567 | Syphilis | 1.9% |
| 568 | Renal Osteodystrophy | 1.9% |
| 569 | Renal rickets | 1.9% |
| 570 | Hyperphosphaturia | 1.7% |
| 571 | Klinefelter Syndrome | 1.7% |
| 572 | Zellweger Syndrome | 1.4% |
| 573 | Familial Hypophosphatemic Rickets | 1% |